Dr. Frank G. Haluska, MD

  • Boston, MA
  • Medical oncologist
NPI1942302559
Publications
21
Industry payments
$247
Medical group
1
State license
1
Year NPI issued
2006
Practice address
750 Washington St, Boston, MA 02111-1526
Practice phone
Call (617) 636-5000
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Tufts Medical Center - Transplant

Hospital · Boston, Massachusetts

See all 2 affiliations

Find Dr. Haluska's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Frank G. Haluska is a medical oncologist in Boston, Massachusetts

Dr. Haluska practices at Tufts Medical Center - Transplant in Boston, Massachusetts.

Dr. Haluska's NPI, 1942302559, was assigned on September 3, 2006. Dr. Haluska holds Massachusetts license 73833.

NPI and contact details
NPI enumeration date
September 3, 2006
NPI status
Active
Practice phone
(617) 636-5000
Professional email
Get email
Personal email
Get email
Mobile number
Get number

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Frank G. Haluska practices at Tufts Medical Center - Transplant in Boston, Massachusetts

Dr. Haluska's primary practice is Tufts Medical Center - Transplant, at 750 Washington St, Boston, MA 02111-1526. The practice phone is (617) 636-5000.

  • Tufts Medical Center - Transplant
    750 Washington St, Boston, MA 02111-1526Phone(617) 636-5000

Source: Doctors and Clinicians National Downloadable File (CMS)

Dr. Frank G. Haluska is affiliated with 1 site of care and 1 medical group

Dr. Haluska's primary practice is Tufts Medical Center - Transplant in Boston, Massachusetts. Dmand AI also links Dr. Haluska to 1 medical group, named with a free account.

Tufts Medical Center - TransplantHospital · Boston, MassachusettsPrimary
1 medical groupName with a free account
See all 2 affiliations for Dr. Haluska

Sources: Doctors and Clinicians National Downloadable File (CMS); and Dmand AI Affiliation Data

Dmand AI tracks the EHR system at Dr. Frank G. Haluska's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Haluska practices. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Tufts Medical Center - TransplantAvailable with a free account
+1 medical groupAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Haluska practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Frank G. Haluska is one of 290 medical oncologists in Massachusetts

Medical oncology is Dr. Haluska's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Haluska is licensed in Massachusetts.

Specialties and state licenses

  • Medical oncology, MassachusettsPrimaryLicense 73833 · taxonomy 207RX0202X

Medical oncologists near Dr. Haluska

Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Frank G. Haluska has 21 publications on record

Dmand AI links 21 papers to Dr. Haluska, published from 2010 to 2017. 2013 was the busiest year, with 8. The most frequent topics are Antineoplastic Agents, Imidazoles and Pyridazines. Dr. Haluska has published most often in J Clin Oncol. Dr. Haluska's most frequent co-authors are Dale Lee Bixby, MD, Ian Winchester Flinn, MD and Michael John Mauro, MD.

Papers21
Years published2010 to 2017

Dr. Haluska's papers by year, 2010 to 2017

Topics Dr. Haluska writes about most

  • Antineoplastic Agents
  • Imidazoles
  • Pyridazines
  • Sirolimus
  • TOR Serine-Threonine Kinases
  • Administration, Oral
  • Area Under Curve
  • Biological Availability

Dr. Haluska's most frequent co-authors

Recent publications by Dr. Haluska

See all 21 publications and co-authors

See who Dr. Haluska researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Haluska works with, so you can find a warm path to the right medical oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Frank G. Haluska received $247 in industry payments in 2025

CMS Open Payments shows 2 general payments to Dr. Haluska from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $247.

Companies that paid Dr. Haluska the most, 2025 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Haluska

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Sources for Dr. Frank G. Haluska's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)
Primary practice, affiliations and health systemDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Dmand AI Affiliation Data
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Industry paymentsOpen Payments (CMS) (opens in a new tab)
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Frank G. Haluska

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Frank G. Haluska's NPI number?

Dr. Frank G. Haluska's NPI number is 1942302559. It was assigned on September 3, 2006, and it is active in the NPI Registry.

What kind of doctor is Dr. Frank G. Haluska?

Dr. Frank G. Haluska is a medical oncologist in Boston, Massachusetts. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).

Where does Dr. Frank G. Haluska practice?

Dr. Haluska practices at 750 Washington St, Boston, MA 02111-1526. Dr. Haluska's primary practice is Tufts Medical Center - Transplant in Boston, Massachusetts. Dmand AI also links Dr. Haluska to 1 medical group.

What is Dr. Frank G. Haluska's office phone number?

The practice phone on file for Dr. Haluska is (617) 636-5000.

What is Dr. Frank G. Haluska's medical license number?

Dr. Haluska holds Massachusetts license 73833.

Has Dr. Frank G. Haluska received payments from drug or device companies?

CMS Open Payments shows $247 in general payments to Dr. Haluska from 1 company from 2025 to 2025. The largest total came from Abbvie Inc.

How long has Dr. Frank G. Haluska been practicing?

Dr. Haluska's NPI was assigned in 2006.

Does Dr. Frank G. Haluska do research?

Dmand AI links 21 publications to Dr. Haluska, published from 2010 to 2017.

Who does Dr. Frank G. Haluska publish with?

Dr. Haluska's most frequent co-authors are Dale Lee Bixby, MD (3 shared papers), Ian Winchester Flinn, MD (3 shared papers) and Michael John Mauro, MD (3 shared papers).

Selling to medical oncology practices?

See medical oncologists in Massachusetts by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)